PHARMACEUTICAL BENEFITS ADVISORY COMMITTEE RECOMMENDATIONS IN AUSTRALIA

Erika Turkstra, Emilie Bettington, Maria L Donohue, Merehau C Mervin

    Research output: Contribution to journalArticle

    Abstract

    Objectives: The aim of this study was to examine submissions made to the Pharmaceutical Benefits Advisory Committee (PBAC) and assess whether the predicted financial impact was associated with a recommendation. The second objective was to assess whether the financial and utilization estimates for listing the proposed medicine were reliable
    Original languageEnglish
    Pages (from-to)521-528pp
    JournalInternational Journal of Technology Assessment in Health Care
    Volume33
    Issue number4
    DOIs
    Publication statusPublished - 2017

    Fingerprint Dive into the research topics of 'PHARMACEUTICAL BENEFITS ADVISORY COMMITTEE RECOMMENDATIONS IN AUSTRALIA'. Together they form a unique fingerprint.

    Cite this